Lembas commercially develops B2B food-and-supplement ingredients; Lembas Edge is a food-grade peptide that helps the body release fullness-signaling hormone GLP-1.
Lembas applies peptide discovery to appetite-regulating food ingredients, drawing on licensed, patent-pending university technology and AI-powered peptide discovery. The company develops functional ingredients for food, beverages and supplements; Lembas Edge is a food-grade bioactive peptide designed to engage the gut’s nutrient-sensing biology and support satiety through endogenous hormone signaling.
Lembas’s food-grade bioactives demonstrated positive results in cell and animal models and stimulated GLP-1 secretion into blood. By contrast, GLP-1 pharmaceuticals are out of reach for many consumers because of lack of accessibility, prohibitive costs and severe side effects. Lembas works with food, beverage, supplement and wellness brands, ingredient companies and manufacturing partners.
